跳到主要导航 跳到搜索 跳到主要内容

The efficacy of initial ventilation strategy for adult immunocompromised patients with severe acute hypoxemic respiratory failure: study protocol for a multicentre randomized controlled trial (VENIM)

  • Tao Wang
  • , Gang Liu
  • , Kun He
  • , Xin Lu
  • , Xianquan Liang
  • , Meng Wang
  • , Rong Zhu
  • , Zongru Li
  • , Feng Chen
  • , Jun Ke
  • , Qingming Lin
  • , Chuanyun Qian
  • , Bo Li
  • , Jie Wei
  • , Jingjun Lv
  • , Li Li
  • , Yanxia Gao
  • , Guofeng Wu
  • , Xiaohong Yu
  • , Weiqin Wei
  • Ying Deng, Fengping Wang, Hong Zhang, Yun Zheng, Hong Zhan, Jinli Liao, Yingping Tian, Dongqi Yao, Jingsong Zhang, Xufeng Chen, Lishan Yang, Jiali Wu, Yanfen Chai, Songtao Shou, Muming Yu, Xudong Xiang, Dongshan Zhang, Fengying Chen, Xiufeng Xie, Yong Li, Bo Wang, Wenzhong Zhang, Yongli Miao, Michael Eddleston, Jianqiang He, Yong Ma, Shengyong Xu, Yi Li*, Huadong Zhu*, Xuezhong Yu*
*此作品的通讯作者
  • Chinese Academy of Medical Sciences - Peking Union Medical College
  • Guiyang Second People Hosp
  • Capital Medical University
  • Fujian Medical University
  • Inner Mongolia Medical University
  • Kunming Medical University
  • Zhengzhou University
  • Guizhou Medical University
  • Harbin Medical University
  • Anhui Medical University
  • Sun Yat Sen University
  • Hebei Medical University
  • Nanjing Medical University
  • Ningxia Medical University
  • Central South University
  • Cangzhou City Ctr Hosp
  • First Hosp Handan City
  • University of Edinburgh

科研成果: 期刊稿件 › 论文 › 同行评审

1 引用 (Scopus)

摘要

["Background: Acute respiratory failure (ARF) is still one of the most severe complications in immunocompromised patients. Our previous systematic review showed noninvasive mechanical ventilation (NIV) reduced mortality, length of hospitalization and ICU stay in AIDS/hematological malignancy patients with relatively less severe ARF, compared to invasive mechanical ventilation (IMV). However, this systematic review was based on 13 observational studies and the quality of evidence was low to moderate. The efficacy of NIV in more severe ARF and in patients with other causes of immunodeficiency is still unclear. We aim to determine the efficacy of the initial ventilation strategy in managing ARF in immunocompromised patients stratified by different disease severity and causes of immunodeficiency, and explore predictors for failure of NIV.","Methods and analysis: The VENIM is a multicentre randomized controlled trial (RCT) comparing the effects of NIV compared with IMV in adult immunocompromised patients with severe hypoxemic ARF. Patients who meet the indications for both forms of ventilatory support will be included. Primary outcome will be 30-day all-cause mortality. Secondary outcomes will include in-hospital mortality, length of stay in hospital, improvement of oxygenation, nosocomial infections, seven-day organ failure, adverse events of intervention, et al. Subgroups with different disease severity and causes of immunodeficiency will also be analyzed.","Discussion: VENIM is the first randomized controlled trial aiming at assessing the efficacy of initial ventilation strategy in treating moderate and severe acute respiratory failure in immunocompromised patients. The result of this RCT may help doctors with their ventilation decisions."]
源语言英语
期刊论文编号127
页数10
期刊BMC PULMONARY MEDICINE
卷17
DOI
出版状态已出版 - 20 9月 2017

基金资助

VENIM is sponsored by the National Natural Science Foundation of China # 81550034 (Yi li) and National Key Clinical Specialty Construction Program in 2012 (No. 20111204). The funders had no role in the study design and will not have any role in execution, analyses, interpretation of the data, or results publication.

联合国可持续发展目标

此成果有助于实现下列可持续发展目标:

  1. 可持续发展目标 3 - 良好健康与福祉
    可持续发展目标 3 良好健康与福祉

关键词

  • Ventilation strategy
  • Noninvasive mechanical ventilation
  • Invasive mechanical ventilation
  • Acute respiratory failure
  • Immunocompromised patients

收录

  • SCIE

学术指纹

探究 'The efficacy of initial ventilation strategy for adult immunocompromised patients with severe acute hypoxemic respiratory failure: study protocol for a multicentre randomized controlled trial (VENIM)' 的科研主题。它们共同构成独一无二的学术指纹。

引用此